Commentary to Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update

High Blood Press Cardiovasc Prev. 2021 May;28(3):251-252. doi: 10.1007/s40292-021-00446-w. Epub 2021 Apr 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Angiotensins
  • COVID-19*
  • Humans
  • Renin-Angiotensin System*
  • SARS-CoV-2

Substances

  • Angiotensins
  • Angiotensin-Converting Enzyme 2